The detected shorter telomeres with the TET2 variant in our population may have hypothetically induced somatic mutations, CH and CHIP-related CAD, which indirectly may have accelerated telomere attrition, although any causality cannot be drawn. This evidence concerns the gene TET2 and coronary artery disorder.